Posted by Michael Wonder on 27 Nov 2018
Pharma agrees to 2 percent cap on branded meds growth
25 November 2018 - The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme with the government, which is expected to come into effect from January.
The voluntary scheme – which is designed to keep growth in the branded medicine bill “predictable and affordable” – will place a 2% cap on the growth in sales of branded medicines to the NHS.
This means that any growth in sales of branded medicines above 2% will be underwritten by the pharma industry, which is expected to save the NHS £930 million next year.
